Literature DB >> 33681225

Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma.

Weixiong Yang1, Chang-Han Chen2, Minghan Jia3, Xiangbin Xing4, Lu Gao5, Hsin-Ting Tsai2, Zhanfei Zhang1, Zhenguo Liu1, Bo Zeng1, Sai-Ching Jim Yeung6, Mong-Hong Lee7,8, Chao Cheng1.   

Abstract

Important evidence indicates the microbiota plays a key role in esophageal squamous cell carcinoma (ESCC). The esophageal microbiota was prospectively investigated in 18 patients with ESCC and 11 patients with physiological normal (PN) esophagus by 16S rRNA gene profiling, using next-generation sequencing. The microbiota composition in tumor tissues of ESCC patients were significantly different from that of patients with PN tissues. The ESCC microbiota was characterized by reduced microbial diversity, by decreased abundance of Bacteroidetes, Fusobacteria, and Spirochaetes. Employing these taxa into a microbial dysbiosis index demonstrated that dysbiosis microbiota had good capacity to discriminate between ESCC and PN esophagus. Functional analysis characterized that ESCC microbiota had altered nitrate reductase and nitrite reductase functions compared with PN group. These results suggest that specific microbes and the microbiota may drive or mitigate ESCC carcinogenesis, and this study will facilitate assigning causal roles in ESCC development to certain microbes and microbiota.
Copyright © 2021 Yang, Chen, Jia, Xing, Gao, Tsai, Zhang, Liu, Zeng, Yeung, Lee and Cheng.

Entities:  

Keywords:  Fusobacteria; carcinogenesis; esophageal squamous cell carcinoma; microbial dysbiosis index; microbiota

Year:  2021        PMID: 33681225      PMCID: PMC7930383          DOI: 10.3389/fcell.2021.641270

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  5 in total

Review 1.  Intratumor microbiome in cancer progression: current developments, challenges and future trends.

Authors:  Jinyan Liu; Yi Zhang
Journal:  Biomark Res       Date:  2022-05-31

2.  Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.

Authors:  Zheng Lin; Wenqing Rao; Zhisheng Xiang; Qiaoyan Zeng; Shuang Liu; Kaili Yu; Jinsong Zhou; Jianwen Wang; Weilin Chen; Yuanmei Chen; Xiane Peng; Zhijian Hu
Journal:  BMC Cancer       Date:  2022-06-24       Impact factor: 4.638

3.  Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma.

Authors:  Zongdan Jiang; Jun Wang; Ziyang Shen; Zhenyu Zhang; Shukui Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-11       Impact factor: 5.293

4.  Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy.

Authors:  Liwei Xu; Yajun Qi; Youhua Jiang; Yongling Ji; Qiang Zhao; Jie Wu; Weishan Lu; Yinjie Wang; Qixun Chen; Changchun Wang
Journal:  Ann Transl Med       Date:  2022-03

5.  Comparison of tumor-associated and nontumor-associated esophageal mucosa microbiota in patients with esophageal squamous cell carcinoma.

Authors:  Baihua Zhang; Qin Xiao; Huahai Chen; Tao Zhou; Yeshi Yin
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.